JPP No 5 2013 article 09 Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac induced gastrointestinal, liver, and encephalopathy lesions ScienceDirect The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and clinics. With BPC 157, TB 500, and others under 503A review, questions around compounding, compliance, and what is Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights BPC 157 Precision Performance Physical Therapy